Lineage Cell Therapeutics (United States)
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Lineage Cell Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
56%
Total
Publications
153
Total Open
Publications
86
Total
Citations
6.9K
Open Access
Percentage
56%
Total
Publications
153
Total Open
Publications
86
Total
Citations
6.9K
Breakdown
Publisher Open
16%
Both
28%
Other Platform Open
12%
Closed
44%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 34%
23
Hybrid 42%
28
No Guarantees 24%
16
Other Platform Open
Domain 82%
51
Other Internet 31%
19
Institution 13%
8
Public 5%
3
Preprint 2%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 50 |
DOI | Other Internet | 16 |
Europe PMC | Domain | 8 |
Unknown Repository | Other Internet | 4 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 4 |
Figshare | Public | 3 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 2 |
University of Oslo - Duo Research Archive | Institution | 2 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 1 |
UNSW Sydney - UNSWorks | Institution | 1 |